Allscripts Healthcare Solutions Investor Presentation — March 2022

Document content

Allscripts Healthcare Solutions

Investor Update, March 3, 20222 Copyright ©2022 Veradigm® | All rights reserved

This presentation contains forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These forward -looking statements, including the

preliminary financial information included in this presentation, are based on the current beliefs and expectations of Allscri ptsmanagement, only speak as of the date that they are

made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “f uture,” “anticipates,” “believes,” “estimates,” “expects,”

“intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual results could differ signif icantly from those set forth in the forward -looking statements

and reported results should not be considered an indication of future performance. Certain factors that could cause Allscript s actual results to differ materially from those described

in the forward -looking statements include, but are not limited to: the timing or ultimate completion of the sale of our Hospital & Large Physician Practices Business; our use of the

proceeds from the sale of our Hospital & Large Physician Practices Business; our ability to achieve the margin targets associ ated with our margin improvement initiatives within the

contemplated time periods, if at all; risks relevant to our share repurchase program, such as general market conditions, fluc tuations in the price of our common stock or changes in

our liquidity or capital allocation strategies; security breaches resulting in unauthorized access to our or our clients’ com puter systems or data, including denial -of-services,

ransomware or other Internet -based attacks; the failure by Practice Fusion to comply with the terms of the settlement agreements with the U.S. Department of Justice (the “DOJ”);

the costs and burdens of compliance by Practice Fusion with the terms of its settlement agreements with the DOJ; additional i nvestigations and proceedings from governmental

entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ’ s investigations into Practice Fusion’ s business practices; our ability to recover

from third parties (including insurers) any amounts paid in connection with Practice Fusion’ s settlement agreements with the DOJ and related inquiries; the expected financial results

of businesses acquired by us; the successful integration of businesses acquired by us; the anticipated and unanticipated exp enses and liabilities related to businesses acquired by us,

including the civil investigation by the U.S. Attorney’ s Office involving our Enterprise Information Solutions business; our failure to compete successfully; consolidation in our